Yokota Takashi, Ishiyama Shuichi, Saito Toshihiro, Teshima Shin, Yamada Yasuo, Iwamoto Kazutsugu, Takahashi Michinori, Murata Katsuyuki, Yamauchi Hidemi
Department of Gastroenterological Surgery, Sendai National Hospital, Miyagino-ku, Sendai 983-8520, Sendai, Japan.
Anticancer Res. 2002 Nov-Dec;22(6B):3673-7.
Retrospective studies using multivariate analysis of clinical and pathological features in gastric cancer have identified a number of high-risk, independent prognostic factors. In these clinical features, tumor size can be measured easily before or during the operation without the requirement of any special equipment, but its prognostic value in patients with gastric cancer is unclear. The aim of this study was to review the experience at our institution of gastric adenocarcinoma to determine the influence of tumor size on outcome.
Between January 1985 and December 1995, 697 patients with gastric adenocarcinoma underwent resection of the stomach at the Department of Surgery, Sendai National Hospital, Japan. Data on age, gender, tumor location, structure and size, evidence of local invasion, and type of operation performed for each patient were obtained. The sizes of tumors were derived from measurements made in fresh resected specimens. The patients were divided into three groups: 102 patients with tumors of less than 2 cm in diameter, 392 patients with tumors of 2-7 cm in diameter, and 203 patients with tumors of more than 7 cm in diameter.
In these three groups, there were statistical differences in tumor location, macroscopic type, depth of invasion, lymph node metastasis, histological type, lymphatic invasion, vascular invasion and cancer-stromal relationship. Patients with larger tumors had more invasion into the gastric wall in terms of depth of invasion and more frequent lymph node metastasis than did patients with smaller tumors. Histologically, diffuse, scirrhous-type was more common in the larger tumor group. The frequency of lymphatic and vascular permeation in the larger tumor group was higher than that in the other groups. The 5-year survival rates according to tumor size were 94.3% in cases of tumors of less than 2 cm, 75.1% in cases of tumors of 2-7 cm, and 26.3% in cases of tumors of more than 7 cm. Multivariate analysis revealed that the prognosis of gastric cancer patients was affected most by depth of invasion, followed by lymph node metastasis and tumor location. Tumor size is not an independent prognostic factor.
In conclusion, according to the results of univariate analysis, tumor size is clinically a predictor of survival of patients with gastric cancer. In multivariate analysis, however, it is not an independent factor, and the presence of lymph node metastasis, depth of invasion and tumor location are more important than tumor size.
利用对胃癌临床和病理特征进行多变量分析的回顾性研究已确定了一些高危、独立的预后因素。在这些临床特征中,肿瘤大小在手术前或手术过程中无需任何特殊设备即可轻松测量,但其对胃癌患者的预后价值尚不清楚。本研究的目的是回顾我院胃腺癌的治疗经验,以确定肿瘤大小对预后的影响。
1985年1月至1995年12月期间,日本仙台国立医院外科有697例胃腺癌患者接受了胃切除术。获取了每位患者的年龄、性别、肿瘤位置、结构和大小、局部侵犯证据以及所施行手术类型的数据。肿瘤大小来自新鲜切除标本的测量值。患者被分为三组:102例直径小于2cm的肿瘤患者,392例直径为2 - 7cm的肿瘤患者,以及203例直径大于7cm的肿瘤患者。
在这三组中,肿瘤位置、大体类型、浸润深度、淋巴结转移、组织学类型、淋巴管浸润、血管浸润以及癌间质关系存在统计学差异。与较小肿瘤患者相比,较大肿瘤患者在浸润深度方面对胃壁的侵犯更多,淋巴结转移更频繁。组织学上,弥漫性、硬癌型在较大肿瘤组中更为常见。较大肿瘤组中淋巴管和血管浸润的频率高于其他组。根据肿瘤大小,直径小于2cm的肿瘤患者5年生存率为94.3%,直径为2 - 7cm的肿瘤患者为75.1%,直径大于7cm的肿瘤患者为26.3%。多变量分析显示,胃癌患者的预后受浸润深度影响最大,其次是淋巴结转移和肿瘤位置。肿瘤大小不是一个独立的预后因素。
总之,根据单变量分析结果,肿瘤大小在临床上是胃癌患者生存的一个预测指标。然而,在多变量分析中,它不是一个独立因素,淋巴结转移、浸润深度和肿瘤位置比肿瘤大小更重要。